Inhibitors of phospholipase A2 block the stimulation of protein synthesis by insulin in L6 myoblasts.
Insulin at a concentration close to the physiological range (100 mu-units/ml) stimulated protein synthesis in L6 myoblasts by 17%. Pre-treatment with the phospholipase A2 inhibitors mepacrine or dexamethasone prevented this stimulation and decreased the release of prostaglandin F2 alpha, implicating the action of phospholipase A2 and the subsequent metabolism of arachidonic acid to prostaglandins in the stimulation of protein synthesis by physiological doses of insulin. Higher concentrations of insulin (500-1000 mu-units/ml) stimulated protein synthesis in the presence of mepacrine or dexamethasone, suggesting that an alternative pathway may become important in insulin action when phospholipase A2 is inhibited.
Southorn
B G
BG
Rowett Research Institute, Bucksburn, Aberdeen, U.K.
Palmer
R M
RM
D001769:Blood; D002460:Cell Line; D003470:Culture Media; D003907:Dexamethasone / Q000494:pharmacology; D015237:Dinoprost / Q000378:metabolism; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology*; D009124:Muscle Proteins / Q000096:biosynthesis*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D011796:Quinacrine / Q000494:pharmacology*
D003470:Culture Media; D007328:Insulin; D009124:Muscle Proteins; D003907:Dexamethasone; D015237:Dinoprost; D010741:Phospholipases A; D054467:Phospholipases A2; D011796:Quinacrine